• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
STIM

STIM

Neuronetics, Inc.

NASDAQHealthcareMedical - Diagnostics & ResearchUS

USD1.39

-0.17 (-10.90%)

Rating:C

Company Profile

CEO

Daniel L. Reuvers

IPO Date

2018-06-28

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.48

Prev. Close

$1.56

Day Low

$1.31

Day High

$1.48

52W Low

$0.80

52W High

$4.85

Market Cap

$0.10B

Volume

1.78M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

32.9%

Avg Negative

4.0%

Avg Neutral

63.1%

News Feed

Neuronetics to Report Second Quarter 2021 Financial and Operating Results and Host Conference Call

GlobeNewsWire·7/20/2021·↑ positive

Neuronetics Launches Enhanced Digital Resource Center for NeuroStar Providers

GlobeNewsWire·7/14/2021·↑ positive

Neuronetics Set to Join Russell 2000® Index

GlobeNewsWire·6/23/2021·↑ positive

Neuronetics, Inc (NVO) CEO Keith Sullivan on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/6/2021·↓ negative

Neuronetics (STIM) Soars 39.2%: Is Further Upside Left in the Stock?

Zacks Investment Research·5/6/2021·↑ positive

Why Neuronetics Blasted 39% Higher Today

The Motley Fool·5/4/2021·↑ positive

STIM Stock: From $10.15 To $11.64 (14.7 Increase) Intraday Explanation

Pulse2·5/4/2021·↑ positive

Neuronetics Announces Retirement of Brian Farley and Appointment of Robert Cascella as Chairman of its Board of Directors

GlobeNewsWire·4/14/2021·↓ negative

Neuronetics Announces Appointment of Robert Cascella to its Board of Directors

GlobeNewsWire·4/1/2021·↑ positive

Neuronetics Announces Retirement of Gregory Harper, Vice President, R&D and Clinical

GlobeNewsWire·3/11/2021·↓ negative